AMBIT BIOSCIENCES CORP's ticker is AMBI and the CUSIP is 02318X100. A total of 36 filers reported holding AMBIT BIOSCIENCES CORP in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2014 | $22,958,000 | +122.9% | 1,490,769 | 0.0% | 0.24% | +98.3% |
| Q2 2014 | $10,301,000 | -24.2% | 1,490,769 | 0.0% | 0.12% | -27.5% |
| Q1 2014 | $13,596,000 | -5.4% | 1,490,769 | 0.0% | 0.17% | -20.9% |
| Q4 2013 | $14,371,000 | -37.8% | 1,490,769 | 0.0% | 0.21% | -48.8% |
| Q3 2013 | $23,107,000 | +121.4% | 1,490,769 | 0.0% | 0.41% | +86.4% |
| Q2 2013 | $10,435,000 | – | 1,490,769 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management I, LLC | 2,079,569 | $18,966,000 | 13.32% |
| GREAT POINT PARTNERS LLC | 719,261 | $6,560,000 | 3.43% |
| Redmile Group, LLC | 367,602 | $3,353,000 | 0.40% |
| WEXFORD CAPITAL LP | 553,843 | $5,051,000 | 0.38% |
| SPHERA FUNDS MANAGEMENT LTD. | 148,468 | $1,354,000 | 0.31% |
| Eventide Asset Management | 131,100 | $1,196,000 | 0.19% |
| Orbimed Advisors | 1,490,769 | $13,596,000 | 0.17% |
| Baker Brothers Advisors | 747,954 | $6,821,000 | 0.09% |
| Artal Group S.A. | 250,000 | $2,280,000 | 0.08% |
| BAILARD, INC. | 35,000 | $319,000 | 0.05% |